Tag:
Stedesa
Latest Headlines
Latest Headlines
FDA declines to approve Dainippon's epilepsy drug
Last fall, when Dainippon Sumitomo Pharma announced that it had inked a deal to buy Sepracor for $2.6 billion , the Japanese pharma company cited the once-daily epilepsy drug Stedesa as one of the
